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Abstract Calreticulin binds Zn 2+ with the relatively high affin- 
it)/low capacity. To determine the location of the Zn 2+ binding 
site in calreticulin different domains of the protein were expressed 
in E. coli, using the glutathione S-transferase fusion protein sys- 
tem, and their Zn2+-dependent interaction with Zn2+-lDA-aga - 
rose were determined. Three distinct domains were used in this 
study: the N + P-domain (the first 290 residues); the N-domain 
(residues 1-182) and the proline-rich P-domain (residues 180- 
273). The N + P-domain bound to the Zn2+-lDA-agarose and 
were eluted with an increasing concentration of imidazole. The 
N-domain also bound 65Zn2+ as measured by the overlay method. 
The P-domain did not interact with the ZnZ+-IDA-agarose and 
it did not bind any detectable amount of Zu 2+. Chemical modifi- 
cation of calreticulin with diethyl pyrocarbonate indicated that 
rise out of seven histidines were protected in the presence of Zn 2+ 
but they were modified by diethyl pyrocarbonate in the absence 
of Zn 2+ suggesting that these residues may be involved in Zn 2+ 
binding to ealreticulin. We conclude that Zn 2+ binding sites in 
calreticulin are localized to the N-domain of the protein, region 
that is not involved in Ca 2+ binding to calreticulin. 
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1. Introduction 
It is well established that Zn 2+ plays an important regulatory 
role in intracellular signal transduction as an activator of tran- 
st ription factors and in several key enzymes involved in animal 
n-etabolism [1,2]. Several Ca 2+ binding proteins including S 100, 
c:,lmodulin and calsequestrin also bind Zn :+ suggesting that 
Z12+ may modulate their structure and function [3,4]. Calretic- 
u in is a Ca 2+ binding protein found in the lumen of the endo- 
p asmic reticulum, in the nuclear envelope and in the nucleus 
o: some cells [5]. Although calreticulin was first identified as a 
( t 2+ binding protein [6], recent reports indicate that the protein 
is multifunctional [7,8]. For example, calreticulin modulates 
st :roid-sensitive gene expression [9], interacts with ~z-subunit of 
ir~tegrin [10], effects adhesion properties of some cells [11], and 
h is a lectin-like activity [12]. Furthermore, calreticulin affects 
ir~ tracellular Ca 2+ homeostasis [13-15], replication of Rubella 
v rus RNA [16] and has a chaperone activity [17,18]. In addition 
t, Ca 2+ calreticulin binds other ions including Mg ~+ and Zn 2+ 
[~ 9,20]. Similarly, the protein has also two distinct Ca 2+ binding 
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sites: a high capacity site (> 25 moles Ca2+/mole of protein) and 
a high affinity site (K a < 10 ¢tM) [6,19]. These two Ca 2+ binding 
sites are found in different structural regions of the molecule. 
The P-domain of calreticulin (a proline-rich central region of 
the protein) binds Ca 2+ with the high affinity and low capacity, 
whereas the C-domain (acidic, carboxyl-terminal region of cal- 
reticulin) binds Ca 2+ with the low affinity and high capacity 
[19]. Localization of the Zn 2+ binding sites in calreticulin is not 
known. 
In the present study we have used the glutathione S-trans- 
ferase (GST) fusion protein system to express distinct domains 
of calreticulin to identify region(s) of the protein involved in 
Zn 2+ binding. Zn 2+ binding site is located to the N-domain of 
calreticulin. Importantly, we showed that the P-domain of cal- 
reticulin does not bind any detectable amount of Zn 2+. DEPC 
modification of calreticulin indicated that 5 out of 7 histidines 
found in calreticulin may be involved in Zn 2+ binding to the 
protein. 
2. Experimental 
Recombinant full-length calreticulin, the domains of calreticulin and 
recombinant GST were expressed in E. coli and purified [19]. In this 
study we have expressed the full length mature calreticulin and several 
domains of the protein: N-domain (amino acid residues 1 to 182), 
N + P-domain (amino acid residues 1 to 290 encoding the N-domain 
and P-domain), the P-domain (amino acid residues 182-273) [19]. 
Zn2+-IDA (iminodiacetate)-substituted agarose chromatography was 
carried out as described by Porath and Olin [21]. Zn2+-IDA-agarose 
column was equilibrated with a solution containing 50 mM NaH2PO4, 
pH 7.0 and 100 mM NaC1 and saturated with 10 mM ZnCI2. Prior to 
the Zn2+-IDA-agarose chromatography, the GST fusion proteins were 
purified on the glutathione-Sepharose 4B column [19] followed by fac- 
tor Xa digestion. Factor Xa was used at a 1 : 50 dilution in a buffer 
containing 100 mM NaCI, 1 mM CaC12 and 50 mM Tris, pH 8.0. The 
reaction was carried out for 18 h at room temperature and was stopped 
with 2.5 mM PMSF. Digested protein samples were directly loaded 
onto the Zn-~+-IDA-agarose. Proteins were eluted with a linear gradient 
of 0 to 50 mM imidazole in 50 mM NaH2PO4, pH 7.0 followed by 
SDS-PAGE analysis. 
Zn2÷-dependent precipitation ofcalreticulin (2 mg of protein/ml) was 
carried out in a buffer containing 10 mM MOPS, pH 7.1, 150 mM NaCI 
and different amounts of ZnCI2. Precipitation was carried out for 16 
h followed by centrifugation for 45 min at 100,000 × g. For 65Zn2+ 
overlay nitrocellulose membranes were incubated in a solution contain- 
ing 10 mM imidazole, pH 6.8, 5 mM MgC12, 60raM KCI in the presence 
of 100/IM 65Zn2+. 65Zn 2+ binding proteins were visualized by autoradi- 
ography on Kodak X-OMAT AR films. 
DEPC modification of histidine residues in calreticulin was carried 
out at 25°C in a buffer containing 50 mM sodium phosphate, pH 7.8 
and 2 pM native or recombinant calreticulin [22]. Aliquots of DEPC 
were added at the time indicated in the Figure in a 35-fold molar excess 
with respect to calreticulin. The modification was monitored by record- 
ing changes in absorbance at 243 nm. Modifications of histidine were 
estimated based on a differential extinction coefficient of 3,200 
M -~ .cm -1 at 243 nm for N-carbethoxyhistidine. 
SDS-PAGE was on 12.5% or 15% polyacrylamide g ls as described 
by Laemmli [23]. After gel electrophoresis, gels were stained with either 
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Coomassie blue or transferred electrophoretically onto nitrocellulose 
membrane for 65Zn2+ overlay or immobilon (polyvinylidene difluoride) 
membrane for NH2-terminal mino acid sequence analysis [24]. 
Protein was determined by the method of Bradford [25] using bovine 
serum albumin as a standard. 
3. Results 
Calreticulin binds ~ 14 moles of Zn2+/mole of protein with a 
Kd of~300 pM [19]. In this study, we have tested effects of Zn 2+ 
on aggregation of calreticulin. Purified protein was incubated 
in the presence of different concentrations of Zn 2+ followed by 
centrifugation and SDS-PAGE of the supematants and pellets. 
Calreticulin was identified by its characteristic blue staining 
with Stains-All [26]. Fig. 1 shows that calreticulin precipitated 
at approximately 600 pM concentration of Zn 2+. In contrast, 
calsequestrin precipitated atapproximately 200 pM Zn 2+ (data 
not shown). Calreticulin was precipitated quantitatively at -2  
mM concentration of Zn 2+ (Fig. 1). 
In order to identify specific domains in calreticulin that might 
be responsible for Zn 2+ binding we utilized a Zn2+-IDA-agarose 
chromatography and fusion protein approaches. Two regions 
of calreticulin were expressed as GST fusion proteins and puri- 
fied: the GST-N + P-domain (amino acid residues 1 to 290), 
GST-N-domain (amino acid residues 1-182), and GST-P-do- 
main (amino acid residues 182-273) (Fig. 2) [19]. The C-domain 
of calreticulin was not used in these studies. Prior to Zn2+-IDA - 
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Fig. 1. Zn2+-Dependent Precipitation ofCalreticulin. Purified calretic- 
ulin was incubated in the presence of increasing concentration ofZn 2+ 
followed by centrifugation. Calreticulin was identified in the superna- 
tants (upper panel) and the pellets (lower panel) by blue staining with 
Stains-All. Co, control; CR, calreticulin. 
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Fig. 2. Schematic representation f calreticulin domains. Three distinct 
domains of calreticulin were used in this study: the N-domain (amino 
acid residues 1-182); the proline-rich P-domain (amino acid residues 
182-273) and the N + P-domain (the first 290 amino acid residues). 
Truncated omain, truncated N + P-domain (see text for details). 
agarose chromatography the fusion proteins were purified on 
the glutathione-Sepharose 4B followed by digestion with factor 
Xa. 
Fig. 3 shows interaction of the N + P-domain with the Zn 2+- 
IDA-agarose. Under the conditions used in this study digestion 
of the N + P-domain with factor Xa resulted in appearance of
three major protein bands of molecular weight of 39,000, 31,000 
and 26,000 (Fig. 3, lanes 2 and 3). A 26-kDa protein band 
corresponded to the recombinant GST. The identity of the 39- 
and 31-kDa protein bands was established by NH2-terminal 
amino acid sequence analysis. The NH2-terminal amino acid 
sequence of the 39-kDa protein band was E-P-A-I-Y-K-. This 
sequence is identical to the NH2-terminal amino acid sequence 
of calreticulin [5] and identifies this protein band as the full 
length N + P-domain (Fig. 3, double arrow head). The NH 2- 
terminal amino acid sequence of the 31-kDa protein band was 
F-Y-A-L-S-A-. This sequence corresponds to amino acid 57 to 
62 in the mature calreticulin [5] and is referred to as the trun- 
cated N + P-domain (Fig. 3, arrow head). It is not clear why 
factor Xa digestion of the N + P-domain produced the trun- 
cated N + P-domain. However, this may be due to a nonspe- 
cific cleavage by the factor Xa. 
To identify if the N + P-domain binds Zn 2+ a mixture of the 
N + P-domain, truncated N + P-domain and GST (Fig. 3, 
lanes 2 and 3) was separated by Zn2+-IDA-agarose chromatog- 
raphy. Zn 2÷ binding proteins interact with Zn2+-IDA-agarose 
and are eluted from the column with an increasing concentra- 
tion of imidazole [21]. The 'flow-through' fractions from Zn 2÷- 
IDA-agarose contain proteins that either do not bind Zn 2+ or 
interact very weakly with Zn 2+. All three proteins (N + P-do- 
main, truncated N + P-domain and GST) bound to the Zn 2+- 
IDA-agarose and were eluted with imidazole (Fig. 3, Bound 
fractions). The full length N + P-domain and the GST were the 
major proteins found in the 'bound' fractions. The major pro- 
tein found in the 'flow-through' fractions (~ 70%) was the trun- 
cated N + P-domain suggesting that this domain (missing the 
NH2-terminal 56 amino acid residues) interacted only weakly 
with the Zn2+-IDA-agarose (Fig. 3, flow-through fractions, 
arrow head). Zn 2÷ binding to the N + P-domain was further 
investigated by 65Zn2+ overlay. Fig. 4 shows that the GST-N- 
domain, the N-domain and the truncated N-domain all bound 
65Zn2+. We concluded that the N-domain of calreticulin binds 
Zn 2+. and that the NH2-terminal portion of the N-domain may 
play an important role in Zn 2+ binding to this region of calretic- 
ulin. 
In order to establish a role of the P-domain in Zn 2+ binding 
to calreticulin the GST-P-domain fusion protein was digested 
with factor Xa, purified by the glutathione-Sepharose 4B 
chromatography and subjected to Zn2+-IDA-agarose chroma- 
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Fi!,~. 3. Zn2+-IDA garose Chromatography of N + P-domain of Calreticulin. N + P domain of calreticulin was expressed in E. eoli and purified [19]. 
The protein was subjected todigestion with Factor Xa followed by Zn2*-IDA-agarose chromatography as described insection 2. Unbound material 
('llow-through' fractions), bound and eluted fractions ('bound' fractions) were separated inSDS-PAGE followed by staining with Coomassie blue. 
Lane 1, purified recombinant GST; lane 2 and 3, purified, factor Xa digested GST-N + P-domain fusion protein (sample loaded onto the Zn2+-IDA - 
a~zarose); S, low molecular Bio-Rad protein standards (97-, 66-, 42-, 31-, 21-kDa). Double arrow head, full length N + P-domain. Arrow head, 
tr ncated N + P-domain. Small arrow indicate the position of GST. 
to graphy. Fig. 5 shows that the P-domain of calreticulin did not 
biad to the ZnZ+-IDA-agarose and was found in the 'flow- 
through' fractions (Fig. 5, arrow head). The identity of the 
P-domain protein band in the 'flow-through' fractions was con- 
firmed by the NH2-terminal mino acid sequence analysis (data 
n~t shown). As expected the 26-kDa GST was found in the 
b~und and eluted fractions (Fig. 5, small arrow). Based on the 
Z~lZ+-IDA-agarose chromatography experiments we concluded 
that Zn 2÷ binding site of calreticulin are located to the N- 
d,,mains but not to the P-domain of the protein. 
The role of histidines in Zn 2+ binding to calreticulin was 
in vestigated by DEPC modification of the protein. DEPC mod- 
ifies histidine and to a much lesser extent yrosine residues in 
proteins and converts them to N-carbethoxyhistidine a d O- 
c, rbethoxytyrosine, r spectively. N-Carbethoxyhistidine and 
O-carbethoxytyrosine ar  characterized by absorbance at 243 
nn  and 278 rim, respectively. No tyrosine residues were modi- 
•4  
1 2 
1: g. 4. 6SZn2+ to the N-domain of Calreticulin. The N-domain of cal- 
n ticulin was expressed in E. coli, purified and digested with factor Xa 
a~ described in section 2. Proteins were separated by SDS-PAGE, 
transferred to nitrocellulose membranes and incubated with 100/.tM 
6~Zn2÷. Lane 1, purified GST-N-domain fusion protein; lane 2, N- 
d~main digested with factor Xa. The protein bands were identified by 
N-terminal amino acid sequence analysis [24]. Double arrow head, 
GST. Arrow head, N-domain. The postion of molecular weight protein 
standards (29-, 20-, 14-, 6-, 3.5-kDa) is indicated by the small arrows. 
fled in the protein as there was no change of absorbance at278 
nm over the time course (data not shown). Fig. 6A shows the 
modification of calreticulin with DEPC as followed by the 
increase of the absorbance at 243 rim. Calreticulin contains 
7 highly conserved histidine residues [8]. Based on the absorb- 
ance spectra in Fig. 5A it was estimated that 7 moles of histidine 
per mole of protein reacted with DEPC in the absence of Zn 2+ 
but only two histidines reacted in the presence of Zn 2+ (Fig. 6B). 
We concluded that Zn 2÷ protected 5 histidines residues from 
DEPC modification and that these 5 histidines became accessi- 
ble to DEPC in the absence of Zn 2+. 
4. Discussion 
In this study we have expressed calreticulin and calreticulin 
domains in E. coli and identified a region in the protein respon- 
sible for Zn 2+ binding. Native calreticulin binds Zn 2+ with a 
relatively high affinity [21]. In order to define the location of 
Zn 2+ binding sites in calreticulin we expressed ifferent do- 
mains of the protein and followed by Zn2+-IDA-agarose 
chromatography and 65Zn2+ overlay, we have localized the high 
affinity Zn 2+ binding site to the NH2-terminal region of calretic- 
ulin (N-domain). A central P-domain of calreticulin did not 
bind any Zn 2+ and did not interact with Zn2*-IDA-agarose 
indicating that this domain is not involved in Zn 2+ binding to 
the protein. The C-domain of calreticulin, a negatively charged 
region which binds Ca 2÷ with high capacity [19], was not used 
in these studies. This region of the protein bound nonspecifi- 
cally a relatively large quantity of Zn 2+ with a very low affinity 
(data not shown) suggesting that it is not physiologically rele- 
vant. GST fusion protein system is a useful system for analysis 
of ion binding to proteins and their domains. GST fusion pro- 
tein approach was also utilized to identify and characterize Zn 2* 
binding to Raf-1 kinase [27] and to LIM homodomain protein 
Isl-2 [28]. 
One of the most important findings of this work is identifica- 
tion of a relatively high affinity Zn 2+ binding site to the N- 
domain of calreticulin, the region of the protein that is not 
involved in Ca 2÷ binding [19]. We showed that the N + P-do- 
main interacted with Zn2÷-IDA-agarose and that the N-domain 
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Fig. 5. Zn2+-IDA garose Chromatography of P-domain of Calreticulin. The P domain of calreticulin was expressed in E. coli, purified and digested 
with factor Xa [18]. The digested protein was used for Zn2+-IDA-agarose chromatography as described in section 2. 'Flow-through' fractions 
(unbound material) and 'bound' fractions (bound and eluted fractions) were analyzed by SDS-PAGE. Lane 1, purified recombinant GST; lane 2 
and 3, purified, factor Xa digested GST-P-domain fusion protein (sample loaded onto the Zn2+-lDA-agarose); S, molecular weight protein standards 
(29-, 20-, 14-, 6-, 3.5-kDa). Arrow head, P-domain. Small arrows indicate the position of GST. 
bound 65Zn2+ under overlay conditions. The N-domain of cal- 
reticulin does not have any consensus amino acid sequences 
such as 'Zn2+-fingers ' known to be associated with Zn 2+ binding 
sites in proteins [1,2,29] making it difficult to predict precisely 
localization of the Zn 2+ binding site(s) in the protein. It is well 
documented that Zn 2+ is bound by multiple cysteine and histid- 
ine residues [1,2,29]. All three cysteines and 5 out of 7 histidines 
found in the mature protein are located in the N-domain of 
calreticulin [5]. Importantly, these amino acid residues are all 
conserved in calreticulin ranging from higher plants to the 
human protein [5]. The remaining two histidines are found in 
the P-domain of the protein, a region which does not bind Zn 2÷. 
Two out of three cysteines found in calreticulin form a disulfide 
bridge (Cys '2° and Cys 146) [30] and, therefore, they are unlikely 
involved in Zn 2÷ binding to the protein. Therefore, histidine 
residues in the N-domain may play an important role in Zn 2÷ 
binding to calreticulin. This is documented by two independent 
observations. First, the truncated N + P-domain (missing 
His 25) does not bind very well to the Zn2÷-IDA-agarose as
compared to the full length N + P-domain suggesting that the 
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Fig. 6. DEPC Modification of Histidines in Calreticulin. DEPC titra- 
tion of calreticulin was carried out as described insection 2. In A, the 
increase of absorbance at243 nm indicates the progressive formation 
of N-carbethoxyhistidine. Successive additions of DEPC are indicated 
by arrows. In B, numbers of the DEPC modified histidines in calretic- 
ulin in the absence and in the presence ofZn 2÷. 
His 25 may be involved in Zn 2+ binding to this domain. Second, 
histidine titration experiments documented that 5 out of 7 his- 
tidine residues found in calreticulin are protected from DEPC 
modification in the presence of Zn 2+ indicating that these 
residues may potentially be involved in Zn 2÷ binding to the 
protein. 
The N-domain of calreticulin is one of the most interesting 
regions of the protein. The amino acid sequence of the N- 
domain is unique to calreticulin and it is highly conserved 
among all calreticulins cloned so far [8]. This region of calretic- 
ulin interacts with the DNA binding domain of the glucocorti- 
coid receptor leading to the modulation of the receptor function 
[9]. The N-domain of calreticulin may also interact with the 
cytoplasmic region of the ~-subunit of integrin and modulate 
adhesion-dependent cell signaling [11]. Zn z÷ may play an im- 
portant role in the control of these protein-protein interactions. 
Little is known about the physiological function of Zn 2÷- 
binding proteins. Although Zn 2+ is under homeostatic control, 
the intracellular distribution of free Zn z+ and its possible role 
in cellular functions i not well established. Increased intracellu- 
lar concentrations of Zn z÷ are found in the nucleus, in the 
synaptic vesicles [31], in the sarcoplasmic reticulum embrane 
subfractions [21] and in secretory granules of some cells [32]. 
These locations are also known to contain calreticulin [5]. Zn z+ 
plays an important role in the regulation of gene expression, 
action of some metaloenzymes [1,2], and the capsid formation 
of human immunodeficiency virus (HIV) [33]. Zn 2+ has also 
been shown to block Ca 2+ influx in some cells [34] and induce 
apoptosis in peripheral blood lymphocytes [35]. Interestingly 
expression of calreticulin is significantly induced in the stimu- 
lated peripheral blood lymphocytes [36]. Therefore, it is essen- 
tial that Zn 2+ homeostasis is under a precise control at the right 
place and at the right time. Calreticulin may play an impor- 
tant role in the regulation of the intracellular levels of Zn 2+ 
and Ca 2÷. 
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